Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 3037 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 13922 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 23179 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 23347 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 40435 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 91116 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 101682 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 133651 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 300695 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 353072 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 380849 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | Peak area normalized | female | diabetic | no neuropathy | |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | Peak area normalized | female | normoglycemic | Neuropathy | |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | Peak area normalized | male | pre-diabetic | Neuropathy |